Siwen Wu

机构：Chinese Academy of Medical Sciences & Peking Union Medical College, Sichuan University, First Affiliated Hospital Zhejiang University, State Key Laboratory of Biotherapy

发表论文 8 篇 · 总被引 105 次 · h-index 4

代表论文

• Myeloid-derived suppressor cells: key immunosuppressive regulators and therapeutic targets in hematological malignancies (2023 · Biomarker Research · 被引 56)
• Gut microbiome influences efficacy of Endostatin combined with PD-1 blockade against colorectal cancer (2024 · Molecular Biomedicine · 被引 16)
• GLP-1RAs attenuated obesity and reversed leptin resistance partly via activating the microbiome-derived inosine/A2A pathway (2024 · Acta Pharmaceutica Sinica B · 被引 13)
• Advances in the Biology, Detection Techniques, and Clinical Applications of Circulating Tumor Cells (2022 · Journal of Oncology · 被引 13)
• Transdermal drugs and delivery strategies: History, advances and future prospects (2025 · Chinese Chemical Letters · 被引 2)
• Designing a Multi-Epitope Vaccine Against MPXV and HIV Based on an Immunoinformatic Approach (2025 · International Journal of Molecular Sciences · 被引 2)